ArticleThe Pan African medical journal2026
Prevalence and determinants of metabolic syndrome among patients with type 2 diabetes mellitus in the Buea Health District, South West Region, Cameroon.
Article in The Pan African medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: metabolic syndrome is a clustering of key cardiovascular risk factors, including abdominal obesity, dyslipidemia, hyperglycemia, and hypertension. Individuals with a combination of metabolic syndrome and type 2 diabetes mellitus (T2DM) have a greater risk of developing microvascular and macrovascular complications, cardiovascular disease, and premature death. This study sought to estimate the prevalence of metabolic syndrome among patients with T2DM in Buea Health District and evaluate its correlation with glycemic control. Methods: a hospital based cross-sectional study was carried out in the Buea Health District from February to May 2024. One hundred and thirty-nine patients with T2DM were recruited by a systematic sampling. Sociodemographic, lifestyle, and clinical data were collected. Evaluation of anthropometric variables, fasting plasma glucose, triglycerides, high-density lipoprotein cholesterol, blood pressure, and glycated hemoglobin was performed. Data were analyzed using the Statistical Package for Social Sciences. The level of significance was set at p < 0.05. Results: a total of 139 patients with T2DM were recruited in this study with a mean (SD) age of 59.5 ± 10.95 years. The prevalence of metabolic syndrome was 64.00% and 56.80% using the International Diabetes Federation and National Cholesterol Education Program Adult Treatment Panel criteria, respectively. The prevalence was significantly higher in women (56.81%). Central obesity, hyperglycemia, and hypertension were the most common components of metabolic syndrome, and they were more prevalent in female patients. Patients with T2DM who were females, older, who consumed alcohol, did not practice self-glucose monitoring, and had poor glycemic control were more likely to have metabolic syndrome (p < 0.05). Conclusion: this study observed a high prevalence of metabolic syndrome among patients with T2DM in Buea, Cameroon. Lifestyle changes and good glycemic control are recommended for the prevention of metabolic syndrome in patients with type 2 diabetes mellitus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.